The Korean Journal of Physiology and Pharmacology

The Korean Society of Pharmacology (대한약리학회)
권호 표지
DOI QR코드

DOI QR Code

Neuroprotective effect of caffeic acid phenethyl ester in 3-nitropropionic acid-induced striatal neurotoxicity

  • Bak, Jia (Department of Pharmaceutical Science and Technology, College of Health and Medical Science, Catholic University of Daegu) ;
  • Kim, Hee Jung (Department of Physiology, College of Medicine, Dankook University) ;
  • Kim, Seong Yun (Department of Pharmacology, Catholic Neuroscience Institute, College of Medicine, The Catholic University of Korea) ;
  • Choi, Yun-Sik (Department of Pharmaceutical Science and Technology, College of Health and Medical Science, Catholic University of Daegu)
  • Received : 2015.12.02
  • Accepted : 2016.03.14
  • Published : 2016.05.01
Download PDF
⟨ Previous Next ⟩

Abstract

Caffeic acid phenethyl ester (CAPE), derived from honeybee hives, is a bioactive compound with strong antioxidant activity. This study was designed to test the neuroprotective effect of CAPE in 3-nitropropionic acid (3NP)-induced striatal neurotoxicity, a chemical model of Huntington's disease (HD). Initially, to test CAPE's antioxidant activity, a 2,2'-azino-bis-3-ethylbenzthiazoline-6-sulfonic acid (ABTS) antioxidant assay was employed, and CAPE showed a strong direct radical-scavenging effect. In addition, CAPE provided protection from 3NP-induced neuronal cell death in cultured striatal neurons. Based on these observations, the in vivo therapeutic potential of CAPE in 3NP-induced HD was tested. For this purpose, male C57BL/6 mice were repeatedly given 3NP to induce HD-like pathogenesis, and 30 mg/kg of CAPE or vehicle (5% dimethyl sulfoxide and 95% peanut oil) was administered daily. CAPE did not cause changes in body weight, but it reduced mortality by 29%. In addition, compared to the vehicle-treated group, robustly reduced striatal damage was observed in the CAPE-treated animals, and the 3NP-induced behavioral deficits on the rotarod test were significantly rescued after the CAPE treatment. Furthermore, immunohistochemical data showed that immunoreactivity to glial fibrillary acidic protein (GFAP) and CD45, markers for astrocyte and microglia activation, respectively, were strikingly reduced. Combined, these data unequivocally indicate that CAPE has a strong antioxidant effect and can be used as a potential therapeutic agent against HD.

Keywords

References

  1. Gil JM, Rego AC. Mechanisms of neurodegeneration in Huntington's disease. Eur J Neurosci. 2008;27:2803-2820. https://doi.org/10.1111/j.1460-9568.2008.06310.x
  2. Semaka A, Creighton S, Warby S, Hayden MR. Predictive testing for Huntington disease: interpretation and significance of intermediate alleles. Clin Genet. 2006;70:283-294. https://doi.org/10.1111/j.1399-0004.2006.00668.x
  3. Ahmed I, Sbodio JI, Harraz MM, Tyagi R, Grima JC, Albacarys LK, Hubbi ME, Xu R, Kim S, Paul BD, Snyder SH. Huntington's disease: neural dysfunction linked to inositol polyphosphate multikinase. Proc Natl Acad Sci U S A. 2015;112:9751-9756. https://doi.org/10.1073/pnas.1511810112
  4. Sepers MD, Raymond LA. Mechanisms of synaptic dysfunction and excitotoxicity in Huntington's disease. Drug Discov Today. 2014;19:990-996. https://doi.org/10.1016/j.drudis.2014.02.006
  5. Ueda M, Li S, Itoh M, Hayakawa-Yano Y, Wang MX, Hayakawa M, Hasebe-Matsubara R, Ohta K, Ohta E, Mizuno A, Hida Y, Matsumoto M, Chen H, Nakagawa T. Polyglutamine expansion disturbs the endoplasmic reticulum formation, leading to caspase-7 activation through Bax. Biochem Biophys Res Commun. 2014;443:1232-1238. https://doi.org/10.1016/j.bbrc.2013.12.114
  6. Quintanilla RA, Jin YN, von Bernhardi R, Johnson GV. Mitochondrial permeability transition pore induces mitochondria injury in Huntington disease. Mol Neurodegener. 2013;8:45. https://doi.org/10.1186/1750-1326-8-45
  7. Jenkins BG, Koroshetz WJ, Beal MF, Rosen BR. Evidence for impairment of energy metabolism in vivo in Huntington's disease using localized 1H NMR spectroscopy. Neurology. 1993;43:2689-2695. https://doi.org/10.1212/WNL.43.12.2689
  8. Feigin A, Leenders KL, Moeller JR, Missimer J, Kuenig G, Spetsieris P, Antonini A, Eidelberg D. Metabolic network abnormalities in early Huntington's disease: an [(18)F]FDG PET study. J Nucl Med. 2001;42:1591-1595.
  9. Costa V, Scorrano L. Shaping the role of mitochondria in the pathogenesis of Huntington's disease. EMBO J. 2012;31:1853-1864. https://doi.org/10.1038/emboj.2012.65
  10. Choi YS, Lee B, Cho HY, Reyes IB, Pu XA, Saido TC, Hoyt KR, Obrietan K. CREB is a key regulator of striatal vulnerability in chemical and genetic models of Huntington's disease. Neurobiol Dis. 2009;36:259-268. https://doi.org/10.1016/j.nbd.2009.07.014
  11. Bhat AH, Dar KB, Anees S, Zargar MA, Masood A, Sofi MA, Ganie SA. Oxidative stress, mitochondrial dysfunction and neurodegenerative diseases; a mechanistic insight. Biomed Pharmacother. 2015;74:101-110. https://doi.org/10.1016/j.biopha.2015.07.025
  12. Jung YJ, Suh EC, Lee KE. Oxygen/glucose deprivation and reperfusion cause modifications of postsynaptic morphology and activity in the CA3 area of organotypic hippocampal slice cultures. Korean J Physiol Pharmacol. 2012;16:423-429. https://doi.org/10.4196/kjpp.2012.16.6.423
  13. Wang X, Stavchansky S, Bowman PD, Kerwin SM. Cytoprotective effect of caffeic acid phenethyl ester (CAPE) and catechol ringfluorinated CAPE derivatives against menadione-induced oxidative stress in human endothelial cells. Bioorg Med Chem. 2006;14:4879-4887. https://doi.org/10.1016/j.bmc.2006.03.015
  14. Michaluart P, Masferrer JL, Carothers AM, Subbaramaiah K, Zweifel BS, Koboldt C, Mestre JR, Grunberger D, Sacks PG, Tanabe T, Dannenberg AJ. Inhibitory effects of caffeic acid phenethyl ester on the activity and expression of cyclooxygenase-2 in human oral epithelial cells and in a rat model of inflammation. Cancer Res. 1999;59:2347-2352.
  15. Lee KW, Chun KS, Lee JS, Kang KS, Surh YJ, Lee HJ. Inhibition of cyclooxygenase-2 expression and restoration of gap junction intercellular communication in H-ras-transformed rat liver epithelial cells by caffeic acid phenethyl ester. Ann N Y Acad Sci. 2004; 1030:501-507. https://doi.org/10.1196/annals.1329.062
  16. Juman S, Yasui N, Ikeda K, Ueda A, Sakanaka M, Negishi H, Miki T. Caffeic acid phenethyl ester suppresses the production of proinflammatory cytokines in hypertrophic adipocytes through lipopolysaccharide-stimulated macrophages. Biol Pharm Bull. 2012;35:1941-1946. https://doi.org/10.1248/bpb.b12-00317
  17. Murtaza G, Karim S, Akram MR, Khan SA, Azhar S, Mumtaz A, Bin Asad MH. Caffeic acid phenethyl ester and therapeutic potentials. Biomed Res Int. 2014. doi: 10.1155/2014/145342.
  18. Kokoszko-Bilska A, Stepniak J, Lewinski A, Karbownik-Lewinska M. Protective antioxidative effects of caffeic acid phenethyl ester (CAPE) in the thyroid and the liver are similar to those caused by melatonin. Thyroid Res. 2014;7:5. https://doi.org/10.1186/1756-6614-7-5
  19. Kassim M, Mansor M, Kamalden TA, Shariffuddin II, Hasan MS, Ong G, Sekaran SD, Suhaimi A, Al-Abd N, Yusoff KM. Caffeic acid phenethyl ester (CAPE): scavenger of peroxynitrite in vitro and in sepsis models. Shock. 2014;42:154-160. https://doi.org/10.1097/SHK.0000000000000179
  20. Saulle E, Gubellini P, Picconi B, Centonze D, Tropepi D, Pisani A, Morari M, Marti M, Rossi L, Papa M, Bernardi G, Calabresi P. Neuronal vulnerability following inhibition of mitochondrial complex II: a possible ionic mechanism for Huntington's disease. Mol Cell Neurosci. 2004;25:9-20. https://doi.org/10.1016/j.mcn.2003.09.013
  21. Huang QY, Wei C, Yu L, Coelho JE, Shen HY, Kalda A, Linden J, Chen JF. Adenosine A2A receptors in bone marrow-derived cells but not in forebrain neurons are important contributors to 3-nitropropionic acid-induced striatal damage as revealed by celltype-selective inactivation. J Neurosci. 2006;26:11371-11378. https://doi.org/10.1523/JNEUROSCI.1907-06.2006
  22. Lee B, Butcher GQ, Hoyt KR, Impey S, Obrietan K. Activitydependent neuroprotection and cAMP response element-binding protein (CREB): kinase coupling, stimulus intensity, and temporal regulation of CREB phosphorylation at serine 133. J Neurosci. 2005;25:1137-1148. https://doi.org/10.1523/JNEUROSCI.4288-04.2005
  23. Koh JY, Choi DW. Quantitative determination of glutamate mediated cortical neuronal injury in cell culture by lactate dehydrogenase efflux assay. J Neurosci Methods. 1987;20:83-90. https://doi.org/10.1016/0165-0270(87)90041-0
  24. Jones BJ, Roberts DJ. The quantitative measurement of motor incoordination in naive mice using an accelerating rotarod. J Pharm Pharmacol. 1968;20:302-304. https://doi.org/10.1111/j.2042-7158.1968.tb09743.x
  25. Ranju V, Sathiya S, Kalaivani P, Priya RJ, Saravana Babu C. Memantine exerts functional recovery by improving BDNF and GDNF expression in 3-nitropropionic acid intoxicated mice. Neurosci Lett. 2015;586:1-7. https://doi.org/10.1016/j.neulet.2014.11.036
  26. Lobsiger CS, Cleveland DW. Glial cells as intrinsic components of non-cell-autonomous neurodegenerative disease. Nat Neurosci. 2007;10:1355-1360. https://doi.org/10.1038/nn1988
  27. Jang M, Lee MJ, Cho IH. Ethyl pyruvate ameliorates 3-nitropropionic acid-induced striatal toxicity through anti-neuronal cell death and anti-inflammatory mechanisms. Brain Behav Immun. 2014;38:151-165. https://doi.org/10.1016/j.bbi.2014.01.015
  28. Yasui N, Nishiyama E, Juman S, Negishi H, Miki T, Yamori Y, Ikeda K. Caffeic acid phenethyl ester suppresses oxidative stress in 3T3-L1 adipocytes. J Asian Nat Prod Res. 2013;15:1189-1196. https://doi.org/10.1080/10286020.2013.825609
  29. Huang Y, Jin M, Pi R, Zhang J, Chen M, Ouyang Y, Liu A, Chao X, Liu P, Liu J, Ramassamy C, Qin J. Protective effects of caffeic acid and caffeic acid phenethyl ester against acrolein-induced neurotoxicity in HT22 mouse hippocampal cells. Neurosci Lett. 2013;535:146-151. https://doi.org/10.1016/j.neulet.2012.12.051
  30. Kurauchi Y, Hisatsune A, Isohama Y, Mishima S, Katsuki H. Caffeic acid phenethyl ester protects nigral dopaminergic neurons via dual mechanisms involving haem oxygenase-1 and brain-derived neurotrophic factor. Br J Pharmacol. 2012;166:1151-1168. https://doi.org/10.1111/j.1476-5381.2012.01833.x
  31. Ilhan A, Iraz M, Gurel A, Armutcu F, Akyol O. Caffeic acid phenethyl ester exerts a neuroprotective effect on CNS against pentylenetetrazol-induced seizures in mice. Neurochem Res. 2004; 29:2287-2292. https://doi.org/10.1007/s11064-004-7038-y
  32. Eser O, Cosar M, Sahin O, Mollaoglu H, Sezer M, Yaman M, Songur A. The neuroprotective effects of caffeic acid phenethyl ester (CAPE) in the hippocampal formation of cigarette smoke exposed rabbits. Pathology. 2007;39:433-437. https://doi.org/10.1080/00313020701444481
  33. Akyol S, Erdemli HK, Armutcu F, Akyol O. In vitro and in vivo neuroprotective effect of caffeic acid phenethyl ester. J Intercult Ethnopharmacol. 2015;4:192-193. https://doi.org/10.5455/jice.20150620024326
  34. Kim H, Kim W, Yum S, Hong S, Oh JE, Lee JW, Kwak MK, Park EJ, Na DH, Jung Y. Caffeic acid phenethyl ester activation of Nrf2 pathway is enhanced under oxidative state: structural analysis and potential as a pathologically targeted therapeutic agent in treatment of colonic inflammation. Free Radic Biol Med. 2013;65:552-562. https://doi.org/10.1016/j.freeradbiomed.2013.07.015
  35. Scapagnini G, Vasto S, Abraham NG, Caruso C, Zella D, Fabio G. Modulation of Nrf2/ARE pathway by food polyphenols: a nutritional neuroprotective strategy for cognitive and neurodegenerative disorders. Mol Neurobiol. 2011;44:192-201. https://doi.org/10.1007/s12035-011-8181-5
  36. Zhang H, Davies KJ, Forman HJ. Oxidative stress response and Nrf2 signaling in aging. Free Radic Biol Med. 2015;88:314-336. https://doi.org/10.1016/j.freeradbiomed.2015.05.036
  37. Wang W, Wu Y, Zhang G, Fang H, Wang H, Zang H, Xie T, Wang W. Activation of Nrf2-ARE signal pathway protects the brain from damage induced by epileptic seizure. Brain Res. 2014;1544:54-61. https://doi.org/10.1016/j.brainres.2013.12.004
  38. Wang R, Tu J, Zhang Q, Zhang X, Zhu Y, Ma W, Cheng C, Brann DW, Yang F. Genistein attenuates ischemic oxidative damage and behavioral deficits via eNOS/Nrf2/HO-1 signaling. Hippocampus. 2013;23:634-647. https://doi.org/10.1002/hipo.22126
  39. Stack C, Ho D, Wille E, Calingasan NY, Williams C, Liby K, Sporn M, Dumont M, Beal MF. Triterpenoids CDDO-ethyl amide and CDDO-trifluoroethyl amide improve the behavioral phenotype and brain pathology in a transgenic mouse model of Huntington's disease. Free Radic Biol Med. 2010;49:147-158. https://doi.org/10.1016/j.freeradbiomed.2010.03.017
  40. Chen YJ, Huang AC, Chang HH, Liao HF, Jiang CM, Lai LY, Chan JT, Chen YY, Chiang J. Caffeic acid phenethyl ester, an antioxidant from propolis, protects peripheral blood mononuclear cells of competitive cyclists against hyperthermal stress. J Food Sci. 2009; 74:H162-167. https://doi.org/10.1111/j.1750-3841.2009.01199.x
  41. Wu W, Lu L, Long Y, Wang T, Liu L, Chen Q, Wang R. Free radical scavenging and antioxidative activities of caffeic acid phenethyl ester (CAPE) and its related compounds in solution and membranes: a structure-activity insight. Food Chem. 2007;105:107-115. https://doi.org/10.1016/j.foodchem.2007.03.049
  42. Bacsi A, Woodberry M, Widger W, Papaconstantinou J, Mitra S, Peterson JW, Boldogh I. Localization of superoxide anion production tomitochondrial electron transport chain in 3-NPA-treated cells. Mitochondrion. 2006;6:235-244. https://doi.org/10.1016/j.mito.2006.07.008
  43. Akashiba H, Ikegaya Y, Nishiyama N, Matsuki N. Differential involvement of cell cycle reactivation between striatal and cortical neurons in cell death induced by 3-nitropropionic acid. J Biol Chem. 2008;283:6594-6606. https://doi.org/10.1074/jbc.M707730200

Cited by

  1. The Neuroprotective Effects of Phenolic Acids: Molecular Mechanism of Action vol.9, pp.5, 2016, https://doi.org/10.3390/nu9050477
  2. Caffeic Acid Phenethyl Ester (CAPE) Protects PC12 Cells from Cisplatin-Induced Neurotoxicity by Activating the NGF-Signaling Pathway vol.34, pp.1, 2016, https://doi.org/10.1007/s12640-017-9849-z
  3. Caffeic acid phenethyl ester (CAPE): pharmacodynamics and potential for therapeutic application vol.66, pp.3, 2019, https://doi.org/10.3897/pharmacia.66.e38573
  4. Natural Products and Their Bioactive Compounds: Neuroprotective Potentials against Neurodegenerative Diseases vol.2020, pp.None, 2020, https://doi.org/10.1155/2020/6565396
  5. Identification of Caffeic Acid Phenethyl Ester (CAPE) as a Potent Neurodifferentiating Natural Compound That Improves Cognitive and Physiological Functions in Animal Models of Neurodegenerative Diseas vol.12, pp.None, 2016, https://doi.org/10.3389/fnagi.2020.561925
  6. Propolis: A useful agent on psychiatric and neurological disorders? A focus on CAPE and pinocembrin components vol.41, pp.2, 2016, https://doi.org/10.1002/med.21757
  7. Recent progresses in the pharmacological activities of caffeic acid phenethyl ester vol.394, pp.7, 2016, https://doi.org/10.1007/s00210-021-02054-w
  8. Plant Polyphenols for Aging Health: Implication from Their Autophagy Modulating Properties in Age-Associated Diseases vol.14, pp.10, 2016, https://doi.org/10.3390/ph14100982